Total Payments
$29,906
2024 Payments
$8,086
Companies
21
Transactions
339
Medicare Patients
579
Medicare Billing
$77,745
Payment Breakdown by Category
Other$24,213 (81.0%)
Food & Beverage$4,382 (14.7%)
Travel$861.55 (2.9%)
Education$449.88 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24,213 | 17 | 81.0% |
| Food and Beverage | $4,382 | 307 | 14.7% |
| Travel and Lodging | $861.55 | 9 | 2.9% |
| Education | $449.88 | 6 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $26,063 | 97 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $917.80 | 67 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $536.77 | 29 | $0 (2024) |
| ITI, Inc. | $517.85 | 44 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $477.59 | 28 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $412.02 | 21 | $0 (2024) |
| Lundbeck LLC | $191.59 | 9 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $140.58 | 7 | $0 (2024) |
| Alkermes, Inc. | $103.90 | 5 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $103.27 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,086 | 86 | ABBVIE INC. ($7,341) |
| 2023 | $11,023 | 95 | ABBVIE INC. ($9,933) |
| 2022 | $9,619 | 81 | ABBVIE INC. ($8,667) |
| 2021 | $1,178 | 77 | ITI, Inc. ($188.17) |
All Payment Transactions
339 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $19.53 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.96 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $15.48 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.26 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.03 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Neuropsychiatry | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $8.24 | General |
| Category: Central Nervous System | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $28.08 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $8.81 | General |
| Category: Neurology | ||||||
| 10/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.25 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: Central Nervous System | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $8.77 | General |
| Category: Central Nervous System | ||||||
| 09/03/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $1.40 | General |
| Category: Central Nervous System | ||||||
| 08/29/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 08/29/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $5.92 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 99 | 269 | $29,397 | $15,217 |
| 2022 | 4 | 143 | 346 | $43,386 | $22,034 |
| 2021 | 8 | 222 | 433 | $49,015 | $29,669 |
| 2020 | 4 | 115 | 243 | $25,107 | $10,826 |
Total Patients
579
Total Services
1,291
Medicare Billing
$77,745
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 161 | $20,162 | $11,498 | 57.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 86 | $8,450 | $3,632 | 43.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 22 | $785.00 | $86.08 | 11.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 227 | $28,300 | $14,394 | 50.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 87 | $8,877 | $4,182 | 47.1% |
| 0240U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid-19), influenza a, and influenza b) in upper respiratory specimen, each reported as detected or not detected | Office | 2022 | 16 | 16 | $3,250 | $2,252 | 69.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 16 | 16 | $2,960 | $1,206 | 40.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 214 | $24,819 | $15,639 | 63.0% |
| 0240U | Nfct ds vir resp rna 3 trgt | Office | 2021 | 28 | 29 | $5,590 | $4,136 | 74.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 29 | 71 | $5,645 | $3,383 | 59.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 13 | 20 | $3,341 | $2,188 | 65.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 26 | 29 | $3,251 | $1,467 | 45.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 14 | 19 | $2,196 | $1,262 | 57.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $2,653 | $889.51 | 33.5% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 37 | 38 | $1,520 | $703.76 | 46.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 44 | 134 | $14,358 | $6,500 | 45.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 25 | 45 | $3,705 | $2,128 | 57.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 35 | 53 | $5,009 | $1,776 | 35.5% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 11 | 11 | $2,035 | $421.98 | 20.7% |
About David Taylor
David Taylor is a Medical healthcare provider based in Morehead City, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2019. The National Provider Identifier (NPI) number assigned to this provider is 1114488640.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Taylor has received a total of $29,906 in payments from pharmaceutical and medical device companies, with $8,086 received in 2024. These payments were reported across 339 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($24,213).
As a Medicare-enrolled provider, Taylor has provided services to 579 Medicare beneficiaries, totaling 1,291 services with total Medicare billing of $77,745. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Morehead City, NC
- Active Since 03/27/2019
- Last Updated 03/27/2019
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1114488640
Products in Payments
- VRAYLAR (Drug) $26,063
- CAPLYTA (Drug) $556.58
- LATUDA (Drug) $477.59
- REXULTI (Drug) $444.76
- INGREZZA (Drug) $412.02
- Austedo XR (Drug) $269.31
- AUSTEDO (Drug) $153.97
- ABILIFY MAINTENA (Drug) $143.40
- INVEGA SUSTENNA (Drug) $121.50
- ARISTADA (Drug) $103.90
- NUEDEXTA (Drug) $97.50
- QELBREE (Drug) $94.39
- HETLIOZ (Drug) $78.31
- VYVANSE (Drug) $58.04
- TRINTELLIX (Drug) $45.23
- ABILIFY ASIMTUFII (Drug) $42.70
- UZEDY (Drug) $35.64
- COBENFY (Drug) $35.01
- Dyanavel XR (Drug) $32.06
- FANAPT (Drug) $24.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Morehead City
James Norris
Medical — Payments: $9,233
Medical $9,233
David Henderson, P.a.-C, P.A.-C
Medical — Payments: $8,638
Medical $8,638
Lauren Thomas, Pa-C, PA-C
Medical — Payments: $8,528
Medical $8,528
Leslie Van Dyke, P.a.-C, P.A.-C
Medical — Payments: $1,197
Medical $1,197
Shanee Savoie, P.a, P.A
Medical — Payments: $1,067
Medical $1,067
John Wheary, Pa-C, PA-C
Medical — Payments: $995.28
Medical $995.28